Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

This publication has 35 references indexed in Scilit:

• Sazetidine-A, A Novel Ligand That Desensitizes α4β2 Nicotinic Acetylcholine Receptors without Activating Them
  Molecular Pharmacology, 2006
• METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
  Drug Metabolism and Disposition, 2006
• 3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation
  Bioorganic & Medicinal Chemistry Letters, 2005
• Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
  Nature Neuroscience, 2005
• Nicotine addiction and comorbidity with alcohol abuse and mental illness
  Nature Neuroscience, 2005
• Mortality in relation to smoking: 50 years' observations on male British doctors
  BMJ, 2004
• Characterization of Human α4β2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells
  Molecular Pharmacology, 2003
• SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Nicotine maintains robust self-administration in rats on a limited-access schedule
  Psychopharmacology, 1989
• Nicotine as a reinforcer in human subjects and laboratory animals
  Pharmacology Biochemistry and Behavior, 1983